NEW YORK (GenomeWeb News) – Akesogen today announced the US Department of Veterans Affairs has awarded the company a five-year, $7.5 million contract to genotype samples from US military veterans as part of the Million Veteran Program.

In the first year of the contract, Akesogen, a genomics and biorepository firm based in Norcross, Ga., will use a custom designed array-based genotyping product from Affymetrix to genotype 105,000 veterans, it said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.